Autobio Diagnostics Co., Ltd.
603658
Rang in aandelen
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Aandeelprijs
$5.15
Laatst gesynchroniseerd: 2026-10-22
Marktkapitalisatie
$2.94B
Verandering (1 dag)
0.97%
Verandering (1 jaar)
-5.80%
Land
CN
Handel Autobio Diagnostics Co., Ltd. (603658)
Categorie
Healthcare
P/S-ratio voor Autobio Diagnostics Co., Ltd. (603658)
P/S-ratio op October 2026 TTM: 4.65
Volgens de meest recente financiële rapporten en aandelenkoers van Autobio Diagnostics Co., Ltd. is de huidige P/S-ratio (TTM) 4.65. Eind 2024 had het bedrijf een P/S-ratio van 5.63.
P/S-ratiohistoriek voor Autobio Diagnostics Co., Ltd. van 2011 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 4.65 | -2.85% |
| 2025 | 4.79 | -15.01% |
| 2024 | 5.63 | -23.73% |
| 2023 | 7.38 | -9.15% |
| 2022 | 8.13 | -5.17% |
| 2021 | 8.57 | -59.04% |
| 2020 | 20.93 | 38.52% |
| 2019 | 15.11 | 50.68% |
| 2018 | 10.03 | -35.35% |
| 2017 | 15.51 | -30.99% |
| 2016 | 22.47 | 104.13% |
| 2015 | 11.01 | -21.97% |
| 2014 | 14.11 | -26.83% |
| 2013 | 19.28 | -24.00% |
| 2012 | 25.37 | -43.23% |
| 2011 | 44.69 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 5.29 | 13.76% |
US
|
|
| 6.43 | 38.09% |
US
|
|
| 21.32 | 358.07% |
US
|
|
| 6.53 | 40.27% |
CN
|
|
| 6.80 | 46.10% |
US
|
